Drug Armamentarium for alopecia areata

Alopecia areata (AA) is a nonscarring, autoimmune hair loss on the scalp, and/or body. The AA occurs in people of all ages and affects 1–2%. Patients with the disease can face significant emotional and psychological stress as a result, there is no cure for the condition. Many therapeutic modalities have been used to treat alopecia areata, with variable efficacy and safety profiles. Unfortunately, none of these agents is curative or preventive. The treatment plan is designed according to the patient’s age and extent of disease. Global Alopecia Treatment Market is valued at USD 2.54 billion in 2018 and expected to reach USD3.98 billion by 2025 with the CAGR of 5.80% over the forecast period. Keywords: Alopecia areata, Corticosteroids, JAK inhibitors, Minoxidil.